Study of infliximab treatment in smokers with COPD: what next?
Russo
Cristina
C
D'Angelo
Francesca
F
Polosa
Riccardo
R
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D000069285:Infliximab; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000276:immunology; D012907:Smoking / Q000276:immunology; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000069285:Infliximab